ClinicalTrials.govpublic full text
Study to Evaluate the Safety and Efficacy of XAV-19 in Patients With COVID-19 Induced Moderate Pneumonia
sars virus, sars-cov-2, covid-19, moderate, pneumonia, antibody, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 860532
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.